Douglass Winthrop Advisors LLC Has $132.82 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Douglass Winthrop Advisors LLC increased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 227,159 shares of the healthcare conglomerate’s stock after buying an additional 410 shares during the quarter. UnitedHealth Group makes up 2.5% of Douglass Winthrop Advisors LLC’s holdings, making the stock its 13th biggest position. Douglass Winthrop Advisors LLC’s holdings in UnitedHealth Group were worth $132,815,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Tealwood Asset Management Inc. bought a new position in UnitedHealth Group during the third quarter worth about $2,905,000. Asset Planning Services Inc. LA ADV increased its holdings in shares of UnitedHealth Group by 1.2% during the 3rd quarter. Asset Planning Services Inc. LA ADV now owns 12,465 shares of the healthcare conglomerate’s stock worth $7,288,000 after acquiring an additional 150 shares during the last quarter. Sequoia Financial Advisors LLC lifted its holdings in UnitedHealth Group by 13.7% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 24,976 shares of the healthcare conglomerate’s stock valued at $14,603,000 after purchasing an additional 3,006 shares during the last quarter. Americana Partners LLC increased its holdings in shares of UnitedHealth Group by 10.8% in the third quarter. Americana Partners LLC now owns 20,377 shares of the healthcare conglomerate’s stock valued at $11,914,000 after purchasing an additional 1,984 shares during the last quarter. Finally, Hennion & Walsh Asset Management Inc. lifted its stake in shares of UnitedHealth Group by 14.8% during the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 9,960 shares of the healthcare conglomerate’s stock worth $5,072,000 after buying an additional 1,283 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several brokerages have issued reports on UNH. Cantor Fitzgerald raised their price objective on shares of UnitedHealth Group from $591.00 to $644.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 16th. KeyCorp assumed coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They issued an “overweight” rating and a $675.00 price objective for the company. Truist Financial reiterated a “buy” rating and issued a $625.00 price target (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, Bank of America decreased their price target on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research report on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $590.87 on Monday. The company has a market capitalization of $543.77 billion, a PE ratio of 38.49, a P/E/G ratio of 1.73 and a beta of 0.58. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a 50-day moving average price of $582.63 and a two-hundred day moving average price of $553.30. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.56 EPS. Analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. UnitedHealth Group’s dividend payout ratio (DPR) is 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.